FMX enters its Q1 2026 results — due today, April 30 — with bears pulling back at an unusually sharp pace, even as the stock slips a touch heading into the print.
Short sellers have been unwinding positions at a striking rate. Estimated short interest fell 39% over the past week to around 480,000 shares, the lowest level in over six weeks. The unwind accelerated through the back half of April: positions peaked above 1 million shares in early April before halving in roughly two weeks. That kind of drawdown signals retreating conviction among short sellers rather than any squeeze mechanics — borrow availability is loose, with cost to borrow a negligible 0.48% APR, and lending availability has widened sharply as shorts have covered. The ORTEX short score has eased in tandem, dropping from a recent peak near 31 to 27.5, comfortably into benign territory.
Options positioning has been more mixed, but the noise is fading into the release. The put/call ratio spiked to 3.4 on April 27 — the highest single-day reading in recent months — before collapsing back to 0.88 Wednesday. That whipsaw looks more like a thin-market roll or expiry distortion than a genuine shift in sentiment. The 20-day average PCR is 0.59, and the current reading is only 0.31 standard deviations above that mean, leaving the options market roughly neutral heading into the report.
The Street has been quietly lifting its view on FEMSA over the past several months. JP Morgan raised its target from $98 to $117 on April 20, keeping a Neutral rating but acknowledging the stock's improved positioning. UBS pushed its Buy target from $109 to $122 in March, and Goldman Sachs raised to $128 back in February. The direction of travel across the analyst community is upward, though the gap between ratings and conviction is visible — JP Morgan is still neutral even with a $117 target against a $112 stock. The consensus mean target is $121, implying around 8% upside from current levels. Valuation looks measured: the P/E is roughly 22.8x, up about 3 points over the past month as the stock recovered, while EV/EBITDA at 52x reflects FEMSA's complex conglomerate structure including its OXXO convenience store network and ownership in Coca-Cola FEMSA. The 6.4% forward yield adds further support for income-oriented holders.
Institutional ownership is substantial and concentrated. Cascade Investment — Bill Gates's family office — holds a 1.7% stake in the broader share base, unchanged as of last quarter. BlackRock added roughly 6.5 million shares in Q1 2026, bringing its holding to around 119 million. Vanguard and Harding Loevner also added modestly. The top-15 institutional holders are almost uniformly long-only, global equity managers, reinforcing the stock's character as a steady emerging-market consumer compounder rather than a high-turnover trading name — context consistent with short interest that, even at its recent peak, remained small in absolute terms.
Among peers, the week was choppy. Closest comparable KOF — Coca-Cola FEMSA, in which FEMSA holds a major stake — was nearly flat on the week. ABEV3 fell about 3.4%, while BUD gained 2.3%. FMX's own 1.4% one-day decline on April 29 looks modest in that context, and its 4% recovery over the past month has outpaced most of the peer group.
The prior two earnings reactions were small but skewed negative in the days following the print: a flat-to-slight dip on the day, then modest declines over the following week. The Q1 release today provides the first real update since FEMSA declared an extraordinary dividend series in late March, payable across 2026 and into early 2027 — the company's stated capital return cadence will be a focal point alongside any update on Proximity Americas (OXXO) volumes and the trajectory of the digital financial services business.
What to watch: whether the sharp short-covering of the past two weeks reflected genuine pre-emptive confidence, or simply position-clearing ahead of a complex macro read on Mexican consumer spending and peso dynamics.
See the live data behind this article on ORTEX.
Open FMX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
